MIST · Forms 3, 4, 5
Insider trades at Milestone Pharmaceuticals Inc.
No open-market insider buys or sells at Milestone Pharmaceuticals Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Milestone Pharmaceuticals Inc. (MIST) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Milestone Pharmaceuticals Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lisa M. Giles | Director | Options or other derivatives | Form 4 | ||||
| Seth H. Z. Fischer | Director | Options or other derivatives | Form 4 | ||||
| Stuart Duty | Director | Options or other derivatives | Form 4 | ||||
| Robert James Wills | Director | Options or other derivatives | Form 4 | ||||
| Michael John Tomsicek | Director | Options or other derivatives | Form 4 | ||||
| Andrew Saik | Director | Options or other derivatives | Form 4 | ||||
| Joseph C Papa | Director | Options or other derivatives | Form 4 | ||||
| Joseph Oliveto | President and CEO | Sell (10b5-1 plan) | 36,500 | $2.26 | $82K | Form 4 | |
| David I. Sandoval | GC & Chief Compliance Officer | Became an insider (Form 3) | Form 3 | ||||
| Lorenz Muller | Chief Commercial Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.